SEC Form D · filed August 3, 2020
GENOCEA BIOSCIENCES, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Gisela Schwab · CAMBRIDGE, MADirectorJessica Flechtner · Cambridge, MAExecThomas Davis · Hamilton HM 12, BermudaExecKatrine Bosley · Cambridge, MADirectorMichael Higgins · HOUSTON, TXDirectorAli Behbahani · South San Francisco, CADirectorGeorge Siber · North Cambridge, MADirectorKenneth Bate · Cambridge, MADirectorWilliam Clark · ALEXANDRIA, VAExecTal S. Kerret · New York, NYExecShawn L. Katz · New York, NYDirectorLisa L. Silverstein · New York, NYExecMelvin L. Kupperman · New York, NYDirectorAli Behbahani · Timonium, MDDirectorGirish Aakalu · Cambridge, MAExecDiantha Duvall · CAMBRIDGE, MAExecHoward Mayer · Cambridge, MADirectorRonald Cooper · Cambridge, MADirectorTimothy N. Yuckman · Birmingham, ALExecSwaroop Kolluri · Cambridge, MADirectorTom Bacon · HOUSTON, TXDirectorJordan Jones · Birmingham, ALExecThomas Davis · Hamilton HM CX, BermudaExecMichael Higgins · London, United KingdomDirectorAli Behbahani · Seattle, WADirectorGirish Aakalu · Cambridge, MAExecDiantha Duvall · CAMBRIDGE, MAExecGisela Schwab · CAMBRIDGE, MADirectorKenneth Bate · Cambridge, MADirectorHoward Mayer · Cambridge, MADirectorRonald Cooper · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗